Stock LAB STANDARD BIOTOOLS INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Standard BioTools Inc.

Equities

LAB

US34385P1084

Real-time Estimate Cboe BZX
Other stock markets
 03:43:00 2024-05-09 pm EDT 		5-day change 1st Jan Change
2.435 USD +8.71% Intraday chart for Standard BioTools Inc. -4.15% +9.73%
May. 08 Transcript : Standard BioTools Inc., Q1 2024 Earnings Call, May 08, 2024
May. 08 Earnings Flash (LAB) STANDARD BIOTOOLS Reports Q1 Revenue $45.5M, vs. Street Est of $46M MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Standard BioTools: Q1 Earnings Snapshot
AQ
Transcript : Standard BioTools Inc., Q1 2024 Earnings Call, May 08, 2024
Earnings Flash (LAB) STANDARD BIOTOOLS Reports Q1 Revenue $45.5M, vs. Street Est of $46M
MT
Standard BioTools Reports First Quarter 2024 Financial Results
AQ
Standard BioTools Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Sector Update: Health Care Stocks Decline Late Afternoon
MT
Sector Update: Health Care
MT
Standard BioTools Initiates Restructuring Plan With 10% Workforce Reduction
MT
Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024
AQ
Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth
AQ
Standard BioTools Inc. Announces Operational Restructuring Plan
CI
TD Cowen Starts Standard BioTools With Buy Rating, $3.50 Price Target
MT
Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging
AQ
Standard BioTools Inc. Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the Boundaries of Tissue Imaging
CI
Jefferies Initiates Coverage on Standard BioTools With Buy Rating, $3.25 Price Target
MT
Sector Update: Health Care Stocks Lean Higher Pre-Bell Thursday
MT
Standard BioTools Enters Into Multi-Year Medicine Research Engagement With Bristol-Myers Squibb
MT
Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine Research
AQ
Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock
AQ
Transcript : Standard BioTools Inc., Q4 2023 Earnings Call, Feb 28, 2024
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LAB Stock
  4. News Standard BioTools Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW